Live Quote · NASDAQEXOZHealthcare· Biotechnology

eXoZymes, Inc.

$8.48 0.24%($-0.02)
TickerSpark Score
39/100
Weak
60
Valuation
20
Profitability
15
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EXOZ research report →

52-Week Range18% of range
Low
$6.33
Current
$8.48
High
$18.40
Company Overviewexozymes.com

About the company

Operating within the United States, eXoZymes, Inc. is a pioneering synthetic biochemical enterprise. The company's primary innovation is SimplePath, a sophisticated platform engineered to synthesize a diverse spectrum of chemicals.

CEO
Michael Heltzen
IPO
2024
Employees
31
HQ
Monrovia, NV, US

Price Chart

-16.86% · this period
$16.50$11.41$6.33Jul 02Dec 31Jul 02
Valuation
Market Cap
$78.71M
P/E
-7.37
P/S
0.00
P/B
46.94
EV/EBITDA
-7.97
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-220.64%
ROIC
-362.40%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-9,158,734 · -56.26%
EPS
$-1.09 · -51.39%
Op Income
$-9,716,471
FCF YoY
25.05%
Performance & Tape
52W High
$18.40
52W Low
$6.33
50D MA
$9.12
200D MA
$11.01
Beta
2.74
Avg Volume
7.86K

Get TickerSpark's AI analysis on EXOZ

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 8, 26Korman Tyler Pazsell750
Apr 9, 26Korman Tyler Pazsell750
Apr 1, 26Perriman Damien Alanother146,437
Apr 1, 26Perriman Damien Alanother62,759
Apr 1, 26Perriman Damien Alanother0
Apr 1, 26Perriman Damien Alanother8,887
Apr 1, 26Opgenorth Paul Hideoother3,999
Apr 1, 26Nawaz Fouadother5,999
Apr 1, 26Korman Tyler Pazother5,332
Jul 2, 25Heltzen Michaelbuy1,040
Coverage · EXOZ

Our EXOZ coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on EXOZ yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate EXOZ report →
Internal Compare

Similar companies

Peers in the same neighborhood.